Comparing Jornay PM vs Qelbree
| Jornay PM (methylphenidate) | Qelbree (viloxazine) |
|
|---|
| Jornay PM (methylphenidate) | Qelbree (viloxazine) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for ADHD. Jornay PM may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for ADHD. Qelbree may also be used for purposes not listed in this medication guide. |
Related suggestions ADHD (Attention Deficit Hyperactivity Disorder)
|
|||||||
| More about Jornay PM (methylphenidate) | More about Qelbree (viloxazine) | ||||||||
| Ratings & Reviews | |||||||||
|
Jornay PM has an average rating of 9.4 out of 10 from a total of 20 ratings on Drugs.com. 85% of reviewers reported a positive effect, while 0% reported a negative effect. |
Qelbree has an average rating of 5.1 out of 10 from a total of 47 ratings on Drugs.com. 38% of reviewers reported a positive effect, while 48% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Jornay PM side effects |
View all Qelbree side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
View all Jornay PM prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | |||||||||
|
N/A |
||||||||
| Brand Names | |||||||||
| Other methylphenidate brands include: Aptensio XR, Concerta, Cotempla XR-ODT, Daytrana, Metadate CD, Methylin, Methylin ER, QuilliChew ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA View more |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
4 hours |
7.02 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
High potential for abuse
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 207 drugs are known to interact with Jornay PM:
|
A total of 286 drugs are known to interact with Qelbree:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
August 08, 2018 |
April 02, 2021 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
|||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.